406 related articles for article (PubMed ID: 25769794)
1. Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.
Shah N; Callander N; Ganguly S; Gul Z; Hamadani M; Costa L; Sengsayadeth S; Abidi M; Hari P; Mohty M; Chen YB; Koreth J; Landau H; Lazarus H; Leather H; Majhail N; Nath R; Osman K; Perales MA; Schriber J; Shaughnessy P; Vesole D; Vij R; Wingard J; Giralt S; Savani BN;
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1155-66. PubMed ID: 25769794
[TBL] [Abstract][Full Text] [Related]
2. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; San Miguel J; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2039-2051. PubMed ID: 26428082
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.
Saad A; Mahindra A; Zhang MJ; Zhong X; Costa LJ; Dispenzieri A; Drobyski WR; Freytes CO; Gale RP; Gasparetto CJ; Holmberg LA; Kamble RT; Krishnan AY; Kyle RA; Marks D; Nishihori T; Pasquini MC; Ramanathan M; Lonial S; Savani BN; Saber W; Sharma M; Sorror ML; Wirk BM; Hari PN
Biol Blood Marrow Transplant; 2014 Mar; 20(3):402-408.e1. PubMed ID: 24342394
[TBL] [Abstract][Full Text] [Related]
4. Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma.
Arora M; McGlave PB; Burns LJ; Miller JS; Barke JN; Defor TE; Weisdorf DJ
Bone Marrow Transplant; 2005 Jun; 35(12):1133-40. PubMed ID: 15834435
[TBL] [Abstract][Full Text] [Related]
5. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.
Nishihori T; Alsina M
Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work.
Bashir Q; Qazilbash MH
Curr Hematol Malig Rep; 2017 Apr; 12(2):126-135. PubMed ID: 28285435
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM
J Clin Oncol; 2006 Sep; 24(25):4150-7. PubMed ID: 16896000
[TBL] [Abstract][Full Text] [Related]
9. Melphalan-based autologous transplant in octogenarian multiple myeloma patients.
Saini NY; Patel R; Varma A; Bashir Q; Delgado R; Rondon G; Popat UR; Hosing CM; Nieto Y; Kebriaei P; Alousi AM; Ahmed S; Weber DM; Thomas SK; Lee HC; Manasanch EE; Patel KK; Orlowski RZ; Champlin RE; Qazilbash MH
Am J Hematol; 2019 Jan; 94(1):E2-E5. PubMed ID: 30300461
[No Abstract] [Full Text] [Related]
10. Strategies to improve the outcome of stem cell transplantation in multiple myeloma.
Catley L; Anderson K
Hematol J; 2004; 5(1):9-23. PubMed ID: 14745425
[TBL] [Abstract][Full Text] [Related]
11. Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.
Perales MA; Ceberio I; Armand P; Burns LJ; Chen R; Cole PD; Evens AM; Laport GG; Moskowitz CH; Popat U; Reddy NM; Shea TC; Vose JM; Schriber J; Savani BN; Carpenter PA;
Biol Blood Marrow Transplant; 2015 Jun; 21(6):971-83. PubMed ID: 25773017
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.
Maffini E; Storer BE; Sandmaier BM; Bruno B; Sahebi F; Shizuru JA; Chauncey TR; Hari P; Lange T; Pulsipher MA; McSweeney PA; Holmberg L; Becker PS; Green DJ; Mielcarek M; Maloney DG; Storb R
Haematologica; 2019 Feb; 104(2):380-391. PubMed ID: 30262560
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.
Wood WA; Deal AM; Abernethy A; Basch E; Battaglini C; Kim YH; Whitley J; Shatten C; Serody J; Shea T; Reeve BB
Biol Blood Marrow Transplant; 2013 Mar; 19(3):450-9. PubMed ID: 23253558
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic Cell Transplantation after Solid Organ Transplantation.
Doney KC; Mielcarek M; Stewart FM; Appelbaum FR
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2123-2128. PubMed ID: 26271193
[TBL] [Abstract][Full Text] [Related]
15. Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
Björkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Gahrton G
J Clin Oncol; 2011 Aug; 29(22):3016-22. PubMed ID: 21730266
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival.
Dhakal B; D'Souza A; Martens M; Kapke J; Harrington AM; Pasquini M; Saber W; Drobyski WR; Zhang MJ; Hamadani M; Hari PN
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):379-86. PubMed ID: 27160644
[TBL] [Abstract][Full Text] [Related]
17. Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.
Rodriguez TE; Hari P; Stiff PJ; Smith SE; Sterrenberg D; Vesole DH
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1391-1396. PubMed ID: 27164062
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation in multiple myeloma.
Pant S; Copelan EA
Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
Burt RK; Marmont A; Oyama Y; Slavin S; Arnold R; Hiepe F; Fassas A; Snowden J; Schuening F; Myint H; Patel DD; Collier D; Heslop H; Krance R; Statkute L; Verda L; Traynor A; Kozak T; Hintzen RQ; Rose JW; Voltarelli J; Loh Y; Territo M; Cohen BA; Craig RM; Varga J; Barr WG
Arthritis Rheum; 2006 Dec; 54(12):3750-60. PubMed ID: 17133541
[No Abstract] [Full Text] [Related]
20. Role of autologous and allogeneic stem cell transplantation in myeloma.
Bensinger WI
Leukemia; 2009 Mar; 23(3):442-8. PubMed ID: 19277049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
